Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Cisneros

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 8, 2012
Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infectionC Martín-Gandul, P Pérez-Romero, M Sánchez, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|August 9, 2012
[Piperacillin-tazobactam in continuous or expanded perfusion vs intermittent perfusion]H Acosta García, M Victoria Gil-Navarro, J Cotrina Luque, et al.
Transplantation Proceedings|May 4, 2005
Comparative study of muromonab-CD3 (OKT3) versus daclizumab (Zenapax) in cardiac transplantation at our centerA Campos, E Lage, R Hinojosa, et al.
Transplantation Proceedings|September 10, 2003
Prevalence of sleep breathing disorders in outpatients on a heart transplant waiting listM Villa, E Lage, E Quintana, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 12, 2005
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide studyJ M Cisneros, J Rodríguez-Baño, F Fernández-Cuenca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1996
Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic featuresJ M Cisneros, M J Reyes, J Pachón, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 22, 2005
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infectionM del Mar Tomas, M Cartelle, S Pertega, et al.
Revista Clinica Espanola|October 16, 1999
[Infectious complications of heart transplantation. A prospective study for the first 6 years of a transplantation program]M Bernabeu-Wittel, E Cañas García-Otero, M Herrero Romero, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2007
False extended-spectrum beta-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acidA Beceiro, F Fernández-Cuenca, A Ribera, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitalsA Ribera, J Vila, F Fernández-Cuenca, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 8, 2012
Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infectionC Martín-Gandul, P Pérez-Romero, M Sánchez, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|August 9, 2012
[Piperacillin-tazobactam in continuous or expanded perfusion vs intermittent perfusion]H Acosta García, M Victoria Gil-Navarro, J Cotrina Luque, et al.
Transplantation Proceedings|May 4, 2005
Comparative study of muromonab-CD3 (OKT3) versus daclizumab (Zenapax) in cardiac transplantation at our centerA Campos, E Lage, R Hinojosa, et al.
Transplantation Proceedings|September 10, 2003
Prevalence of sleep breathing disorders in outpatients on a heart transplant waiting listM Villa, E Lage, E Quintana, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 12, 2005
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide studyJ M Cisneros, J Rodríguez-Baño, F Fernández-Cuenca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1996
Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic featuresJ M Cisneros, M J Reyes, J Pachón, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 22, 2005
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infectionM del Mar Tomas, M Cartelle, S Pertega, et al.
Revista Clinica Espanola|October 16, 1999
[Infectious complications of heart transplantation. A prospective study for the first 6 years of a transplantation program]M Bernabeu-Wittel, E Cañas García-Otero, M Herrero Romero, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2007
False extended-spectrum beta-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acidA Beceiro, F Fernández-Cuenca, A Ribera, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitalsA Ribera, J Vila, F Fernández-Cuenca, et al.
Pageof 9